On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Beactica Therapeutics AB's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€2.2M · 6 projects
- Horizon Europe€1.6M · 2 projects
- Horizon 2020€596k · 3 projects
Projects
11 EU-funded projects, newest first. Beactica Therapeutics AB led 2 of them as coordinator. Each links to the official record.
- GLIOBREAKCoordinator
Developing a new treatment and companion diagnostic to improve outcomes for glioblastoma patients
Horizon Europe · 2026–2028 · Project on CORDIS ↗
€1.6Mtheir share - SciLifeLab PULSEAssociated partner
SciLifeLab Programme for fUture Leaders in life SciencE
Horizon Europe · 2025–2030 · Project on CORDIS ↗
- UBIMOTIFPartner
Short linear interaction motifs as specificity determinants in the ubiquitin system – discovery, mechanisms and therapeutic opportunities
Horizon 2020 · 2019–2024 · Project on CORDIS ↗
€282ktheir share - EpiGlioTCoordinator
Epigenetic Glioblastoma Therapeutics
Horizon 2020 · 2018–2018 · Project on CORDIS ↗
€50ktheir share - €264ktheir share
- ENABLEPartner
European Gram Negative Antibacterial Engine
FP7 (2007 to 2013) · 2014–2020 · Project on CORDIS ↗
€170ktheir share - FLUCUREPartner
Development of novel antiviral drugs against Influenza
FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗
€708ktheir share - SYNSYSPartner
Synaptic Systems: dissecting brain function in health and disease
FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗
€445ktheir share - BRAINTRAINPartner
BrainTrain: Integrative neuroscience school on brain function and disease
FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗
€215ktheir share - FLUDRUGSTRATEGYPartner
Combating influenza using a novel drug strategy
FP7 (2007 to 2013) · 2008–2010 · Project on CORDIS ↗
€302ktheir share - NEUROCYPRESPartner
Neurotransmitter Cys-loop receptors: structure, function and disease
FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗
€355ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Stichting VuNetherlands · 6 shared projects
- Vereniging Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek en PatientenzorgNetherlands · 5 shared projects
- Kobenhavns UniversitetDenmark · 4 shared projects
- Karolinska InstitutetSweden · 3 shared projects
- Uppsala UniversitetSweden · 3 shared projects
- European Molecular Biology LaboratoryGermany · 3 shared projects
- Institut PasteurFrance · 3 shared projects
- Vib vzwBelgium · 3 shared projects
- Synaptologics BVNetherlands · 3 shared projects
- Glaxosmithkline Research & Development LimitedUnited Kingdom · 3 shared projects
- Katholieke Universiteit LeuvenBelgium · 2 shared projects
- Institut National de la Sante et de la Recherche MedicaleFrance · 2 shared projects
- Helsingin YliopistoFinland · 2 shared projects
- University College LondonUnited Kingdom · 2 shared projects
- Universitat de BarcelonaSpain · 2 shared projects
- Universitaetsklinikum FreiburgGermany · 2 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- antibiotic resistance
- antibiotics
- antivirals
- clinical microbiology
- computational science
- coronaviruses
- crystallography
- drug discovery
- employment
- enzymes
- epilepsy
- genetics
- genomes
- immunotherapy
Beactica Therapeutics AB is listed on EUACC
See the startup profile for its product, team and what it is looking for.
Open the startup profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
